<DOC>
	<DOCNO>NCT01899118</DOCNO>
	<brief_summary>Neoadjuvant ( preoperative ) concomitant chemoradiotherapy ( CRT ) consider standard treatment locally advance rectal adenocarcinoma , correlate well local control high sphincter preservation rate . Nimotuzumab , humanize monoclonal antibody epidermal growth factor receptor ( EGFR ) report improve therapeutic effect radiotherapy cancer . This study clinical phase II trial design evaluate efficacy combination Nimotuzumab administer concurrently neoadjuvant chemoradiotherapy patient locally advanced rectal cancer , investigate side-effect toxicity .</brief_summary>
	<brief_title>Nimotuzumab Combination With Chemoradiation Patients With Locally Advanced Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1 . Written inform consent 2 . Age:1875 year 3 . Histologically confirm locally advanced colorectal cancer ( adenocarcinoma ) 4 . The low edge tumor locate 12 cm anal verge 5 . Karnofsky Performance Scale ≥70 point , Life expectancy ≥ 6 month 6 . No prior chemotherapy use 7 . No history regional radiation treatment inthe pelvic cavity 8 . Adequate hematologic function : Hb ≥ 100 g/L , WBC≥3.5×109 , ANC ≥ 1.5×109 /L，PLT ≥ 100×109 /L Adequate renal function : Cr ≤ 1.5×ULN , TB≤2.5 × ULN Adequate hepatic function : ALT/AST ≤ 2.5×ULN , Alkaline phosphatase ≤ 2.5×ULN 9 . Patients without peripheral neuropathy 1 . Other malignant tumor , except skin basal cell carcinoma , cervical carcinoma situ 2 . Rectal cancer patient concurrent colon cancer 3 . Pregnant lactate woman 4 . Fertile female patient without use contraceptive 5 . Allergic cisplatin fluorouracil 6 . Patients previous peripheral neuropathy 7 . Serious complication : myocardial infarction , heart failure ( NYHA Classification &gt; II grade ) , psychiatric history severe diabetes 8 . Treatment anticancer therapy ( include Chinese herbal medicine ) 9 . Organ transplant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>locally advanced rectal cancer</keyword>
	<keyword>Neoadjuvant chemoradiotherapy</keyword>
	<keyword>Nimotuzumab</keyword>
</DOC>